What's in Erin McCreary's pipeline?

Erin McCreary has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Erin McCreary's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/erin-mccreary.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Erin McCreary — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Erin McCreary pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Lilly Bamlanivimab	Lilly Bamlanivimab	marketed
Lilly Bamlanivimab + Etesevimab	Lilly Bamlanivimab + Etesevimab	marketed	Monoclonal antibody combination (neutralizing antibodies)	SARS-CoV-2 spike protein receptor-binding domain	Infectious Disease / Virology
Regeneron Casirivimab + Imdevimab	Regeneron Casirivimab + Imdevimab	marketed	Monoclonal antibody combination (neutralizing antibodies)	SARS-CoV-2 spike protein	Infectious Disease / Virology

Therapeutic area mix

Infectious Disease / Virology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Erin McCreary:

Cite this brief

Drug Landscape (2026). Erin McCreary — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/erin-mccreary. Accessed 2026-05-16.